259 related articles for article (PubMed ID: 15147329)
1. Role of Toll-like receptor 4 in the initiation and progression of atherosclerotic disease.
Pasterkamp G; Van Keulen JK; De Kleijn DP
Eur J Clin Invest; 2004 May; 34(5):328-34. PubMed ID: 15147329
[TBL] [Abstract][Full Text] [Related]
2. Innate immunity and toll-like receptors: clinical implications of basic science research.
Abreu MT; Arditi M
J Pediatr; 2004 Apr; 144(4):421-9. PubMed ID: 15069387
[TBL] [Abstract][Full Text] [Related]
3. Toll-like receptor 4 is involved in outward arterial remodeling.
Hollestelle SC; De Vries MR; Van Keulen JK; Schoneveld AH; Vink A; Strijder CF; Van Middelaar BJ; Pasterkamp G; Quax PH; De Kleijn DP
Circulation; 2004 Jan; 109(3):393-8. PubMed ID: 14699006
[TBL] [Abstract][Full Text] [Related]
4. Toll-like receptor (TLR)-3, but not TLR4, agonist protects against genital herpes infection in the absence of inflammation seen with CpG DNA.
Ashkar AA; Yao XD; Gill N; Sajic D; Patrick AJ; Rosenthal KL
J Infect Dis; 2004 Nov; 190(10):1841-9. PubMed ID: 15499542
[TBL] [Abstract][Full Text] [Related]
5. Signal integration following Toll-like receptor triggering.
Dalpke A; Heeg K
Crit Rev Immunol; 2002; 22(3):217-50. PubMed ID: 12498384
[TBL] [Abstract][Full Text] [Related]
6. Functional consequences of the Asp299Gly Toll-like receptor-4 polymorphism.
van der Graaf C; Kullberg BJ; Joosten L; Verver-Jansen T; Jacobs L; Van der Meer JW; Netea MG
Cytokine; 2005 Jun; 30(5):264-8. PubMed ID: 15927851
[TBL] [Abstract][Full Text] [Related]
7. Multiple roles of Toll-like receptor signaling in atherosclerosis.
Björkbacka H
Curr Opin Lipidol; 2006 Oct; 17(5):527-33. PubMed ID: 16960501
[TBL] [Abstract][Full Text] [Related]
8. Toll-like receptors, endogenous ligands, and systemic autoimmune disease.
Rifkin IR; Leadbetter EA; Busconi L; Viglianti G; Marshak-Rothstein A
Immunol Rev; 2005 Apr; 204():27-42. PubMed ID: 15790348
[TBL] [Abstract][Full Text] [Related]
9. Various members of the Toll-like receptor family contribute to the innate immune response of human epidermal keratinocytes.
Köllisch G; Kalali BN; Voelcker V; Wallich R; Behrendt H; Ring J; Bauer S; Jakob T; Mempel M; Ollert M
Immunology; 2005 Apr; 114(4):531-41. PubMed ID: 15804290
[TBL] [Abstract][Full Text] [Related]
10. No evidence for involvement of the Toll-like receptor 4 (TLR4) A896G and CD14-C260T polymorphisms in susceptibility to ankylosing spondylitis.
van der Paardt M; Crusius JB; de Koning MH; Morré SA; van de Stadt RJ; Dijkmans BA; Peña AS; van der Horst-Bruinsma IE
Ann Rheum Dis; 2005 Feb; 64(2):235-8. PubMed ID: 15647432
[TBL] [Abstract][Full Text] [Related]
11. [Toll type receptors: molecular bases of the relationship between innate and adaptation responses of the immune system].
Moreno C; Sánchez-Ibarrola A
Rev Med Univ Navarra; 2003; 47(3):29-33. PubMed ID: 14727572
[TBL] [Abstract][Full Text] [Related]
12. Heat shock up-regulates expression of Toll-like receptor-2 and Toll-like receptor-4 in human monocytes via p38 kinase signal pathway.
Zhou J; An H; Xu H; Liu S; Cao X
Immunology; 2005 Apr; 114(4):522-30. PubMed ID: 15804289
[TBL] [Abstract][Full Text] [Related]
13. Toll-like receptor 2 and Toll-like receptor 4 expression in human adrenals.
Bornstein SR; Schumann RR; Rettori V; McCann SM; Zacharowski K
Horm Metab Res; 2004 Jul; 36(7):470-3. PubMed ID: 15305230
[TBL] [Abstract][Full Text] [Related]
14. LPS, TLR4 and infectious disease diversity.
Miller SI; Ernst RK; Bader MW
Nat Rev Microbiol; 2005 Jan; 3(1):36-46. PubMed ID: 15608698
[TBL] [Abstract][Full Text] [Related]
15. Toll-like receptors and other links between innate and acquired alloimmunity.
Goldstein DR
Curr Opin Immunol; 2004 Oct; 16(5):538-44. PubMed ID: 15341996
[TBL] [Abstract][Full Text] [Related]
16. Toll-like receptor 2 stimulation induces intimal hyperplasia and atherosclerotic lesion development.
Schoneveld AH; Oude Nijhuis MM; van Middelaar B; Laman JD; de Kleijn DP; Pasterkamp G
Cardiovasc Res; 2005 Apr; 66(1):162-9. PubMed ID: 15769459
[TBL] [Abstract][Full Text] [Related]
17. [Toll-like receptors and the significance for clinical medicine].
Wiersinga WJ; van der Poll T
Ned Tijdschr Geneeskd; 2005 May; 149(21):1150-5. PubMed ID: 15940918
[TBL] [Abstract][Full Text] [Related]
18. The toll-like receptor 4 Asp299Gly variant: no influence on LPS responsiveness or susceptibility to pulmonary tuberculosis in The Gambia.
Newport MJ; Allen A; Awomoyi AA; Dunstan SJ; McKinney E; Marchant A; Sirugo G
Tuberculosis (Edinb); 2004; 84(6):347-52. PubMed ID: 15525557
[TBL] [Abstract][Full Text] [Related]
19. Infection of C57BL/10ScCr and C57BL/10ScNCr mice with Leishmania major reveals a role for Toll-like receptor 4 in the control of parasite replication.
Kropf P; Freudenberg N; Kalis C; Modolell M; Herath S; Galanos C; Freudenberg M; Müller I
J Leukoc Biol; 2004 Jul; 76(1):48-57. PubMed ID: 15039466
[TBL] [Abstract][Full Text] [Related]
20. Toll-like receptors as potential therapeutic targets for multiple diseases.
Zuany-Amorim C; Hastewell J; Walker C
Nat Rev Drug Discov; 2002 Oct; 1(10):797-807. PubMed ID: 12360257
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
